Abstract:Transcatheter aortic valve therapies are the newest established techniques for the treatment of high risk patients affected by severe symptomatic aortic valve stenosis. The transapical approach requires a left anterolateral mini-thoracotomy, whereas the transfemoral method requires an adequate peripheral vascular access and can be performed fully percutaneously. Alternatively, the trans-subclavian access has been recently proposed as a third promising approach. Depending on the technique, the fine stent-valve positioning can be performed with or without contrast injections. The transapical echo-guided stent-valve implantation without angiography (the Lausanne technique) relies entirely on transoesophageal echocardiogramme imaging for the fine stent-valve positioning and it has been proved that this technique prevents the onset of postoperative contrast-related acute kidney failure. Recent published reports have shown good hospital outcomes and short-term results after transcatheter aortic valve implantation, but there are no proven advantages in using the transfemoral or the transapical technique. In particular, the transapical series have a higher mean logistic Euroscore of 27-35%, a procedural success rate above 95% and a mean 30-day mortality between 7.5 and 17.5%, whereas the transfemoral results show a lower logistic Euroscore of 23-25.5%, a procedural success rate above 90% and a 30-day mortality of 7-10.8%. Nevertheless, further clinical trials and long-term results are mandatory to confirm this positive trend. Future perspectives in transcatheter aortic valve therapies would be the development of intravascular devices for the ablation of the diseased valve leaflets and the launch of new stent-valves with improved haemodynamic, different sizes and smaller delivery systems.

Transcatheter aortic valve implantation in patients with anomalous origin of a coronary artery

Emergently Alteration of Procedural Strategy During Transcatheter Aortic Valve Replacement to Prevent Coronary Occlusion: A Case Report

Expansion of indications for transcatheter aortic valve replacement

The best way to transcatheter aortic valve implantation: From standard to new approaches

Alternative access in transcatheter aortic valve replacement-an updated focused review

[Transcatheter Aortic Valve Implantation in a Large Aortic Annulus: A Case Report]

Update of Transcatheter Valve Treatment

Transcatheter aortic valve implantation (TAVI): state of the art techniques and future perspectives

Evaluation and management of coronary artery disease in patients undergoing transcatheter aortic valve implantation

Clinical considerations and challenges in TAV-in-TAV procedures

Recent developments and controversies in transcatheter aortic valve implantation

Transcatheter Aortic Valve Implantation for Severe Chronic Aortic Regurgitation

Considering alternatives to transcatheter heart valves for managing patients with severe aortic valve stenosis

Percutaneous Coronary Intervention in Transcatheter Aortic Valve Implantation Patients: Overview and Practical Management

Transcatheter Aortic Valve Implantation to Treat Degenerated Aortic, Mitral and Tricuspid Bioprosthesis

Transcarotid TAVR for Severe Bicuspid Aortic Stenosis With Virtually Atretic Coarctation of the Thoracic Aorta

Transcatheter Aortic Valve Implantation for Aortic Regurgitation: A Comprehensive Review

Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation

Challenges and future opportunities for transcatheter aortic valve therapy

Exploring Optimal Strategies for Surgical Access in Transcatheter Aortic Valve Implantation

Engineering perspective on transcatheter aortic valve implantation